CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 53 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $5,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | -37.5% | 2,000 | 0.0% | 0.00% | – |
Q4 2017 | $8,000 | +60.0% | 2,000 | 0.0% | 0.00% | – |
Q3 2017 | $5,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
Q2 2017 | $6,000 | +50.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2017 | $4,000 | +100.0% | 2,000 | 0.0% | 0.00% | – |
Q4 2016 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q3 2016 | $2,000 | +100.0% | 2,000 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2016 | $2,000 | -60.0% | 2,000 | 0.0% | 0.00% | – |
Q4 2015 | $5,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
Q3 2015 | $6,000 | -25.0% | 2,000 | 0.0% | 0.00% | – |
Q2 2015 | $8,000 | -38.5% | 2,000 | -33.3% | 0.00% | – |
Q1 2015 | $13,000 | -7.1% | 3,000 | -45.5% | 0.00% | – |
Q2 2014 | $14,000 | +16.7% | 5,500 | 0.0% | 0.00% | – |
Q1 2014 | $12,000 | -29.4% | 5,500 | 0.0% | 0.00% | -100.0% |
Q3 2013 | $17,000 | – | 5,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |